Summary:
- Existing arthritis drugs may help treat long-term lung damage caused by COVID-19 infection, according to a new study.
- Researchers found that drugs like baricitinib, which are used to treat rheumatoid arthritis, can reduce lung inflammation and fibrosis in COVID-19 patients.
- The study suggests these repurposed arthritis drugs could be a promising therapeutic option for managing the long-term respiratory complications associated with severe COVID-19 cases.